GlassScriptPhysician profile
Raymund S Cordero
NPI 1003822347
$10,197.38
in general payments reported to CMS, 2019-2025
18 companies · $6,121 in 2025
The $6,121 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $338 · 2021: $189 · 2022: $742 · 2023: $567 · 2024: $1,967 · 2025: $6,121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,852 · Travel and Lodging: $1,961 · Food and Beverage: $1,843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,851.66 |
| Travel and Lodging | $1,960.90 |
| Food and Beverage | $1,843.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,558.16 | 2024-2025 | |
| Medtronic, INC. | $557.38 | 2021-2025 | Signia, Eea |
| Integra Lifesciences Corporation | $473.96 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Covidien LP | $352.66 | 2019-2020 | |
| Ethicon US, LLC | $289.28 | 2023-2024 | Ethicon, Echelon Flex, Mega Soft |
| Cumberland Pharmaceuticals, INC. | $202.48 | 2020-2022 | |
| Stryker Corporation | $149.93 | 2025 | Spy-Phi System |
| Veryan Medical Incorporated | $133.34 | 2022 | |
| Solventum Corporation | $110.51 | 2024 | Prevena |
| Innocoll Pharmaceuticals Limited | $88.24 | 2022 | |
| Kci USA, INC. | $76.49 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $61.74 | 2019 | |
| Becton, Dickinson and Company | $61.39 | 2023 | Phasix Mesh |
| Argon Medical Devices, INC. | $20.02 | 2024 | Clot Management |
| Cook Medical LLC | $18.66 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $16.14 | 2020 | |
| Tela Bio, INC. | $14.12 | 2019 | |
| Boston Scientific Corporation | $12.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymund Cordero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.